GGrantIndex
Sort

53,477 grants matching addiction

MDMA Dependence and Discontinuation Syndrome

$461,918
California Pacific Med Ctr Res Institute · R01 · FY2005 · DA

Implementation of Federal Mental Health Parity

$461,868
Colleen L Barry · Johns Hopkins University · R01 · FY2013 · MH

Project 1

$461,849
Sanford M Simon · Mayo Clinic Rochester · P50 · FY2024 · CA

Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers

$461,848
Michael D Stein · Butler Hospital (Providence, Ri) · R01 · FY2008 · CA

Research Project 2

$461,833
Jennifer Rai Richards · Johns Hopkins University · P50 · FY2023 · DA

Regulated trafficking and compartmentalized signaling of opioid receptors

$461,790
Manojkumar A Puthenveedu · University Of Michigan At Ann Arbor · R01 · FY2023 · DA

Regulated trafficking and compartmentalized signaling of opioid receptors

$461,789
Manojkumar A Puthenveedu · University Of Michigan At Ann Arbor · R01 · FY2025 · DA

Regulated trafficking and compartmentalized signaling of opioid receptors

$461,789
Manojkumar A Puthenveedu · University Of Michigan At Ann Arbor · R01 · FY2024 · DA

Pharmacological and behavioral effects of MCAM: a long-acting, μ opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder

$461,788
William P Clarke · University Of Texas Hlth Science Center · R01 · FY2020 · DA

Pharmacological and behavioral effects of MCAM: a long-acting, μ opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder

$461,788
William P Clarke · University Of Texas Hlth Science Center · R01 · FY2021 · DA

Pharmacological and behavioral effects of MCAM: a long-acting, μ opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder

$461,788
William P Clarke · University Of Texas Hlth Science Center · R01 · FY2019 · DA

Causes and Health Consequences of Synthetic Drug Abuse

$461,749
Xiushi Yang · Old Dominion University · R01 · FY2018 · DA

RESEARCH ADOLESCENTS FOR PREVENTION

$461,725
Boston University Medical Campus · P60 · FY2004 · AA

Treatment-Induced Phenotypic Reprogramming in Prostate Cancer

$461,699
Natasha Kyprianou · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA

CB-1 Antagonists for Cannabis Addiction

$461,674
Jack Bergman · Mclean Hospital · R01 · FY2007 · DA

Project 1: Cardiovascular Toxicity of Tobacco Products

$461,670
Sanjay Srivastava · American Heart Association · P50 · FY2016 · HL

Stress Response and Smoking Cessation in Depressed Youth

$461,621
University Of Texas Sw Med Ctr/Dallas · R01 · FY2003 · DA

Genetic Epidemiology of Opioid Dependence in Bulgaria

$461,612
Alexandre A Todorov · Washington University · R01 · FY2009 · DA

Cell type transcriptional mechanisms of polysubstance choice

$461,523
Peter James Hamilton · Virginia Commonwealth University · R01 · FY2025 · DA

Membrane Trafficking of Opioid and Adrenergic Receptors

$461,523
Mark E. Von Zastrow · University Of California, San Francisco · R01 · FY2019 · DA

T32 Translational Addiction Research Fellowship Program

$461,457
Anna Rose Childress · University Of Pennsylvania · T32 · FY2017 · DA

UCSF-Kaiser Department of Research Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Program

$461,426
Claire D. Brindis · University Of California, San Francisco · K12 · FY2022 · HD

PATHOLOGICAL GAMBLING--COURSES, CONSEQUENCES, AND CAUSES

$461,404
Washington University · R01 · FY2002 · MH

Behavioral Treatment of Adolescent Marijuana Use

$461,392
Alan Jeffrey Budney · Univ Of Arkansas For Med Scis · R01 · FY2007 · DA

Trending: Social media analysis to monitor cannabis and synthetic cannabinoid use

$461,348
Raminta Daniulaityte · Wright State University · R01 · FY2015 · DA